1-5 of 5
Emily A. Egusa
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Synthetic Lethal Targeting of CDK12-Deficient Prostate Cancer with PARP Inhibitors

Available to Purchase
Jonathan Chou, Troy M. Robinson, Emily A. Egusa, Roshan Lodha, Meng Zhang, Michelle Badura, Mane Mikayelyan, Henry M. Delavan, Jason Swinderman, Chris Wilson, Jun Zhu, Rajdeep Das, Minh Nguyen, Andrea Loehr, Tony Golsorkhi, Andrew Simmons, Wassim Abida, Arul M. Chinnaiyan, Michelle R. Arkin, Eric J. Small, David A. Quigley, Lixing Yang, Minkyu Kim, Alan Ashworth, Felix Y. Feng
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (23): 5445–5458.
https://doi.org/10.1158/1078-0432.CCR-23-3785
Published: 02 December 2024
View articletitled, Synthetic Lethal Targeting of CDK12-Deficient Prostate Cancer with PARP Inhibitors
Open the PDF for Synthetic Lethal Targeting of CDK12-Deficient Prostate Cancer with PARP Inhibitors in another window
Includes: Supplementary data
Journal Articles

Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy

Open Access
Anil P. Bidkar, Sinan Wang, Kondapa Naidu Bobba, Emily Chan, Scott Bidlingmaier, Emily A. Egusa, Robin Peter, Umama Ali, Niranjan Meher, Anju Wadhwa, Suchi Dhrona, Chandrashekhar Dasari, Denis Beckford-Vera, Yang Su, Ryan Tang, Li Zhang, Jiang He, David M. Wilson, Rahul Aggarwal, Henry F. VanBrocklin, Youngho Seo, Jonathan Chou, Bin Liu, Robert R. Flavell
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (10): 1916–1928.
https://doi.org/10.1158/1078-0432.CCR-22-3291
Published: 15 May 2023
View articletitled, Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy
Open the PDF for Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy in another window
Includes: Supplementary data
Journal Articles

CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease

Available to Purchase
Ning Zhao, Shalini Chopra, Kai Trepka, Yung-Hua Wang, Sasank Sakhamuri, Nima Hooshdaran, Hyunjung Kim, Jie Zhou, Shion A. Lim, Kevin K. Leung, Emily A. Egusa, Jun Zhu, Li Zhang, Adam Foye, Renuka Sriram, Emily Chan, Youngho Seo, Felix Y. Feng, Eric J. Small, Jonathan Chou, James A. Wells, Rahul Aggarwal, Michael J. Evans
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (14): 3066–3075.
https://doi.org/10.1158/1078-0432.CCR-21-3858
Published: 15 July 2022
View articletitled, CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease
Open the PDF for CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease in another window
Includes: Supplementary data
Journal Articles

Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

Available to Purchase
Carissa E. Chu, Martin Sjöström, Emily A. Egusa, Ewan A. Gibb, Michelle L. Badura, Jun Zhu, Vadim S. Koshkin, Bradley A. Stohr, Maxwell V. Meng, Raj S. Pruthi, Terence W. Friedlander, Yair Lotan, Peter C. Black, Sima P. Porten, Felix Y. Feng, Jonathan Chou
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (18): 5123–5130.
https://doi.org/10.1158/1078-0432.CCR-20-4175
Published: 15 September 2021
View articletitled, Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin
Open the PDF for Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin in another window
Includes: Supplementary data
Journal Articles

Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET

Available to Purchase
Sinan Wang, Jun Li, Jun Hua, Yang Su, Denis R. Beckford-Vera, Walter Zhao, Mayuri Jayaraman, Tony L. Huynh, Ning Zhao, Yung-hua Wang, Yangjie Huang, Fujun Qin, Sui Shen, Daniel Gioeli, Robert Dreicer, Renuka Sriram, Emily A. Egusa, Jonathan Chou, Felix Y. Feng, Rahul Aggarwal, Michael J. Evans, Youngho Seo, Bin Liu, Robert R. Flavell, Jiang He
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (5): 1305–1315.
https://doi.org/10.1158/1078-0432.CCR-20-3310
Published: 01 March 2021
View articletitled, Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET
Open the PDF for Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET in another window
Includes: Supplementary data